Nissui Corporation TSE:1332

Nissui : Financial Statements (February 6, 2026) Consolidated Financial Results

Published

Source: MarketScreener

‌Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

February 6, 2026

Consolidated Financial Resultsfor the Nine Months Ended December 31, 2025 (Under Japanese GAAP)

Company name: Nissui Corporation Listing: Tokyo Stock Exchange Securities code: 1332

URL: https://www.nissui.co.jp

Representative: Teru Tanaka Representative Director, President & CEO Inquiries: Yoichiro Hiroi Executive Officer, General Manager of

Corporate Strategic Planning & IR Department

Telephone: +81-3-6206-7037

Scheduled date to commence dividend payments: -

Preparation of supplementary material on financial results: Yes Holding of financial results briefing: Yes

(Yen amounts are rounded down to millions, unless otherwise noted.)

  1. Consolidated financial results for the nine months ended December 31, 2025 (from April 1, 2025 to December 31, 2025)
    1. Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Nine months ended

      December 31, 2025

      December 31, 2024

      Millions of yen

      689,755

      663,337

      %

      4.0

      6.1

      Millions of yen

      31,418

      24,840

      %

      26.5

      (5.7)

      Millions of yen

      33,791

      27,907

      %

      21.1

      0.5

      Millions of yen

      22,346

      19,578

      %

      14.1

      (3.5)

      Note: Comprehensive income

      For the nine months ended December 31, 2025:

      ¥

      23,868 million [

      7.3%]

      For the nine months ended December 31, 2024:

      ¥

      22,237 million [

      (39.8) %]

      Basic earnings per share

      Diluted earnings per share

      Nine months ended

      Yen

      Yen

      December 31, 2025

      73.08

      -

      December 31, 2024

      62.99

      -

    2. Consolidated financial position

    Total assets

    Net assets

    Equity-to-asset ratio

    As of

    December 31, 2025

    March 31, 2025

    Millions of yen

    686,801

    634,878

    Millions of yen

    293,966

    285,939

    %

    41.3

    43.6

    Reference: Equity

    As of December 31, 2025:

    ¥

    283,986 million

    As of March 31, 2025:

    ¥

    277,039 million

  2. Cash dividends

    Annual dividends per share

    First quarter-end

    Second quarter-end

    Third quarter-end

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended March 31, 2025

    -

    12.00

    -

    16.00

    28.00

    Fiscal year ending March 31, 2026

    -

    14.00

    -

    Fiscal year ending March 31, 2026

    (Forecast)

    18.00

    32.00

    Note: Revisions to the forecast of cash dividends most recently announced: Yes

  3. Consolidated financial results forecasts for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)

(Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings per share

Full year

Millions of

yen

928,000

%

4.7

Millions of

yen

38,000

%

19.6

Millions of

yen

41,000

%

16.1

Millions of yen

27,500

%

8.3

Yen

90.68

Note: Revisions to the financial results forecast most recently announced: Yes

* Notes
  1. Significant changes in the scope of consolidation during the period: Yes

    Newly included: - companies( )

    Excluded: 1 companies( Seinan Suisan Co., Ltd. )

  2. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: None

  3. Changes in accounting policies, changes in accounting estimates, and restatement

    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

    2. Changes in accounting policies due to other reasons: None

    3. Changes in accounting estimates: None

    4. Restatement: None

  4. Number of issued shares (common shares)

    1. Total number of issued shares at the end of the period (including treasury shares)

      As of December 31, 2025

      312,430,277 shares

      As of March 31, 2025

      312,430,277 shares

    2. Number of treasury shares at the end of the period

      As of December 31, 2025

      9,157,598 shares

      As of March 31, 2025

      1,607,331 shares

    3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Nine months ended December 31, 2025

305,775,750 shares

Nine months ended December 31, 2024

310,826,935 shares

(Note) Nissui has introduced the “Board Benefit Trust (BBT)” as its performance-linked and share-based compensation plan since FY2018 and, from the first quarter of the current consolidated period, has changed to the “Board Benefit Trust-Restricted Stock (BBT-RS).” In addition, its own shares remaining in the Trust is included as treasury shares. The number of treasury stocks at the end of the term was 307,526, and the average number of the term was 464,826.

  • Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: None

  • Proper use of earnings forecasts, and other special matters

The performance forecasts in this report are based on information available at present and certain premises thought to be reasonable. Accordingly, the results may change substantially due to various factors. For conditions from which the premises for the forecasts were derived and the other noteworthy items relating to the use of the forecasts, please refer to (3) Explanation of Consolidated Financial Forecasts on page 8 under 1. Qualitative Information for the Third Quarter of the Fiscal Year Ending March 31, 2026.

  1. ‌Qualitative Information for the Third Quarter of the Fiscal Year Ending March 31, 2026

    1. Explanation of Consolidated Financial Results

      During the nine months ended December 31, 2025, the Japanese economy continued its moderate recovery, driven by increased inbound demand and improvements in employment and income conditions. However, uncertainty persists due to downside economic risks stemming from geopolitical risks and the U.S. tariff policies, as well as consumers growing propensity to cut spending in response to rising prices.

      Regarding the global economy (from January to September), although the economy remained firm mainly in Europe and the United States, uncertainty remained high due to ongoing geopolitical risks, and the economic environment continued to be unclear.

      Under the Medium Term Management Plan “GOOD FOODS Recipe 2, launched in April 2025, our company and its group are reinforcing their business portfolio by pursuing (1) growth in international business, (2) advancement of the aquaculture business, and (3) turnaround of unprofitable operations.

      During the nine months ended December 31, 2025, the fishery and aquaculture business and the North American seafood processing business, both of which had struggled in the previous fiscal year, continued to improve. Also, the domestic trading business and the processed food business saw signs of recovery. The chilled foods business remained firm.

      In the current situation, our consolidated business performance for the third quarter cumulative period is as follows: net sales were 689,755 million yen, up 26,418 million yen year-on-year; operating profit was 31,418 million yen, up 6,577 million yen year-on-year; ordinary profit was 33,791 million yen, up 5,884 million yen year-on-year; and profit attributable to owners of parent was 22,346 million yen, up 2,768 million yen year-on-year.

      (Unit: million yen)

      Net Sales

      Operating Profit

      Ordinary Profit

      Profit attributable to

      owners of parent

      3Q of FY2025

      689,755

      31,418

      33,791

      22,346

      3Q of FY2024

      663,337

      24,840

      27,907

      19,578

      Difference

      26,418

      6,577

      5,884

      2,768

      Percentage difference (%)

      104.0%

      126.5%

      121.1%

      114.1%

      The summary by segment is as follows.

      (Unit: million yen)

      Net Sales

      Increase

      /Decrease (Y-on-Y)

      Y-on-Y

      Operating Profit & loss

      Increase

      /Decrease (Y-on-Y)

      Y-on-Y

      Marine Products

      279,180

      8,539

      103.2%

      12,463

      7,327

      242.7%

      Food Products

      375,638

      19,526

      105.5%

      24,064

      326

      101.4%

      Fine Chemicals

      11,433

      669

      106.2%

      234

      39

      120.1%

      General Distribution

      12,739

      56

      100.4%

      2,084

      (242)

      89.6%

      Other (Note)

      10,762

      (2,374)

      81.9%

      366

      (398)

      47.9%

      Common Costs

      -

      -

      -%

      (7,795)

      (473)

      106.5%

      Total

      689,755

      26,418

      104.0%

      31,418

      6,577

      126.5%

      (Note) “Other” refers to Engineering (planning, design, construction of plants and equipment) business,

      Ship Operation Business, etc.

      1. Marine Products Business

        The Marine Products segment is engaged in the fishery, aquaculture, and seafood processing and trading businesses.

        We recorded 279,180 million yen (up 8,539 million yen year-on-year) in sales and operating profit of 12,463 million yen (up 7,327 million yen year-on-year) in the Marine Products Business.

        Fishery Business: Both sales and profit increased year on year. [Japan]

        • Catches of Japanese amberjack, Japanese jack mackerel, and tuna remained solid, resulting in higher sales and profits.

          [South America]

        • Catch volume declined due to a reduction of one vessel; however, sales decreased while profit increased due to cost reductions.

          Aquaculture Business: Both sales and profit increased year on year. [Japan]

        • Although competition in tuna intensified due to increased supplies of wild-caught and imported tuna, increased production of coho salmon, improved aquaculture performance, and higher sales prices of Japanese amberjack contributed to decreased sales but increased profit overall.

          [South America]

        • Aquaculture performance improved due to higher survival rates, and sales prices increased due to a market recovery, resulting in higher sales and profits.

          Processing and Trading Business: Both sales and profit increased year on year. [Japan]

        • Although performance improved from the third quarter onward due to increased sales volume of fish oil and the effect of price revisions for salmon and trout, sales and profit decreased on a cumulative basis, reflecting the impact of the first half.

          [North America]

        • In the processing business, in addition to the pollock fillet production ratio improving, higher sales prices of surimi also contributed, resulting in a significant improvement. In the trading business, sales remained firm, particularly for group products such as salmon and trout, cod, and crab. As a result, sales and profit increased.

          [Europe]

        • Although sales remained firm in Italy, the Benelux countries, and UK, sales increased but profit decreased due to higher expenses associated with CSRD compliance, among other factors.

      2. Food Products Business

        The Food Products segment is engaged in the food processing and chilled foods businesses.

        We recorded 375,638 million yen (up 19,526 million yen year-on-year) in sales and an operating profit of 24,064 million yen (up 326 million yen year-on-year) in the Food Products Business.

        Processed Foods Business: Sales increased but profit decreased year on year. [Japan]

        • Sales of fish sausages and fish cakes for household use continued to perform well, and frozen products for food service, including restaurants and supermarket delicatessen counters, remained solid. However, profit decreased due to a time lag in the effects of price revisions implemented in response to higher raw material costs, and a decline in sales volume following the price revisions, especially in household frozen foods.

          [North America]

          • For household use, sales remained firm and expanded market share, while the food service segment struggled amid weaker dining out demand and the impact of rising prices due to the U.S. tariff policies. Overall, sales increased, but profits decreased.

            [Europe]

          • Strong sales in France, Italy, and Spain, as well as in the UK, together with sufficient inventories of white-meat fish raw material held ahead of the price increases, generated higher profits.

            Chilled Foods Business: Both sales and profits increased year on year.

          • Effective sales promotions at convenience stores drove continued strong sales of bento and delicatessen items, resulting in higher sales and profits.

      3. Fine Chemicals Business

        The Fine Chemicals segment is engaged in manufacturing and selling pharmaceutical raw materials, functional raw materials (Note 1), and functional foods (Note 2).

        We recorded 11,433 million yen (up 669 million yen year-on-year) in sales and an operating profit of 234 million yen (up 39 million yen year-on-year) in the Fine Chemicals Business.

        • Sales of pharmaceutical materials and domestic sales of functional raw materials for supplements remained firm, resulting in higher sales and profits.

      4. General Distribution Business

        The General Distribution segment is engaged in cold storage, transportation, and customs clearance businesses.

        We recorded 12,739 million yen (up 56 million yen year-on-year) in sales and an operating profit of 2,084 million yen (down 242 million yen year-on-year) in the General Distribution Business.

        • Increased personnel expenses associated with additional staffing amid the logistics “2024 problem,” together

      with higher fuel costs, resulted in higher sales but lower profits.

      (Note 1) EPA, DHA, and others mainly used as ingredients in health supplements and infant formula.

      (Note 2) Supplements such as “Sesame soy milk” functional food and “i-mark S,” food for specified health

      uses (FOSHU), mainly for online business.

    2. Explanation of the consolidated financial position

      State of assets, liabilities, and net assets

      (Unit: million yen)

      FY2024

      3Q of FY2025

      Increase/Decrease

      Current Assets

      332,568

      365,705

      33,136

      (Inventories)

      195,008

      200,522

      5,513

      Non-current Assets

      302,309

      321,095

      18,785

      Total Assets

      634,878

      686,801

      51,922

      Current Liabilities

      226,179

      234,889

      8,709

      Non-current Liabilities

      122,758

      157,945

      35,186

      Total Liabilities

      348,938

      392,834

      43,895

      Total Net Assets

      285,939

      293,966

      8,026

      Assets

      Total assets increased by 51,922 million yen to 686,801 million yen compared to the end of the previous consolidated fiscal year (up 8.2%).

      Current assets increased by 33,136 million yen to 365,705 million yen (up 10.0%). This is mainly because notes and accounts receivable increased by 20,318 million yen reflecting higher sales, and the inventory increased by 5,513 million yen.

      Non-current assets increased by 18,785 million yen to 321,095 million yen (up 6.2%), mainly due to an increase of 12,654 million yen in property, plant and equipment driven by capital investment and other factors.

      Liabilities

      Total liabilities increased by 43,895 million yen to 392,834 million yen compared to the end of the previous consolidated fiscal year (up 12.6%).

      Current liabilities increased by 8,709 million yen to 234,889 million yen (up 3.9%), mainly because of increased accrued expenses by 5,372 million yen and notes and accounts payable by 5,098 million yen.

      Non-current liabilities increased by 35,186 million yen to 157,945 million yen (up 28.7%). The main reason was an increase in long-term borrowings by 31,469 million yen.

      Net Assets

      Total net assets increased by 8,026 million yen to 293,966 million yen compared to the end of the previous consolidated fiscal year (up 2.8%). This is mainly due to posting a profit attributable to owners of the parent of 22,346 million yen, payment of dividends of 9,237 million yen, as well as an increase in treasury stock by 5,861 million yen due to the tender offer, among other factors.

    3. Explanation of Consolidated Financial Forecasts

      With the fishery and aquaculture business and the North American seafood processing business continuing to improve, and the chilled foods business remaining firm and exceeding the plan through the third quarter, as well as signs of recovery in the domestic Marine Products Business and Food Products Business that had struggled, we have revised our outlook as follows.

      As for the year-end dividend forecast for the fiscal year ending March 2026, we have revised the forecast upward by 4 yen per share to 18 yen.

      For details, please refer to the “Notice Concerning Revision to Dividend Forecasts for the Fiscal Year Ending March 31, 2026” released today.

      Revision of Full-Year Consolidated Earnings Forecast for the Fiscal Year Ending March 2026 (April 1, 2025 – March 31, 2026)

      (Unit: million yen)

      Net Sales

      Operating profit

      Ordinary profit

      Profit attributabl e to owners of parent

      Profit attributable to owners of parent per share

      (Yen per

      share)

      Previous forecast

      (A)

      900,000

      34,500

      35,500

      25,000

      82.52 yen

      Revised forecast (B)

      928,000

      38,000

      41,000

      27,500

      90.68 yen

      Difference (B-A)

      28,000

      3,500

      5,500

      2,500

      -

      Change (%)

      3.1

      10.1

      15.5

      10.0

      -

      Reference:

      Actual results

      (FY2024) (C)

      886,126

      31,779

      35,301

      25,381

      81.66 yen

      Difference (B-C)

      41,873

      6,220

      5,698

      2,118

      -

      Change vs. FY2024

      (%)

      4.7

      19.6

      16.1

      8.3

      -

      Revision of Segment Performance Forecast for the Fiscal Year Ending March 2026 (April 1, 2025 – March 31, 2026)

      Reference:

      (Unit: million yen)

      Previous forecast (A)

      Revised forecast (B)

      Difference (B-A)

      Actual results (FY2024)

      (C)

      Difference (B-C)

      Net Sales

      900,000

      928,000

      28,000

      886,126

      41,873

      Marine Products

      Business

      356,800

      376,500

      19,700

      364,057

      12,442

      Food Products

      Business

      490,100

      501,700

      11,600

      471,058

      30,641

      Fine Chemicals

      Business

      18,300

      16,800

      (1,500)

      15,844

      955

      General

      Distribution

      16,700

      16,700

      0

      16,536

      163

      Others

      18,100

      16,300

      (1,800)

      18,628

      (2,328)

      Operating Profit

      34,500

      38,000

      3,500

      31,779

      6,220

      Marine Products

      Business

      12,750

      16,000

      3,250

      8,418

      7,581

      Food Products

      Business

      27,850

      28,450

      600

      28,711

      (261)

      Fine Chemicals

      Business

      1,400

      1,450

      50

      891

      558

      General

      Distribution

      2,550

      2,500

      (50)

      2,838

      (338)

      Others

      950

      400

      (550)

      925

      (525)

      Common Costs

      (11,000)

      (10,800)

      200

      (10,006)

      (793)

  2. ‌Quarterly Consolidated Financial Statements and Primary Notes (1)Quarterly Consolidated Balance Sheet

(Millions of yen)

As of March 31, 2025

As of December 31, 2025

Assets

Current assets

Cash and deposits

14,707

21,436

Notes and accounts receivable - trade

107,400

127,719

Merchandise and finished goods

102,564

108,237

Work in process

33,172

35,482

Raw materials and supplies

59,271

56,802

Other

16,067

16,595

Allowance for doubtful accounts

(616)

(569)

Total current assets

332,568

365,705

Non-current assets

Property, plant and equipment

Buildings and structures, net

68,204

76,535

Other, net

112,734

117,058

Total property, plant and equipment

180,939

193,593

Intangible assets

Goodwill

2,120

1,719

Other

14,929

14,049

Total intangible assets

17,050

15,769

Investments and other assets

Investment securities

30,453

34,519

Shares of subsidiaries and associates

49,398

51,253

Long-term loans receivable

8,158

9,706

Retirement benefit asset

330

218

Deferred tax assets

4,489

3,055

Other

12,695

14,244

Allowance for doubtful accounts

(1,204)

(1,265)

Total investments and other assets

104,320

111,733

Total non-current assets

302,309

321,095

Total assets

634,878

686,801

(Millions of yen)

As of March 31, 2025

As of December 31, 2025

Liabilities

Current liabilities

Notes and accounts payable - trade

56,439

61,538

Short-term borrowings

114,104

115,519

Income taxes payable

3,639

3,579

Accrued expenses

29,121

34,493

Provisions

4,436

2,163

Other

18,437

17,594

Total current liabilities

226,179

234,889

Non-current liabilities

Long-term borrowings

95,832

127,302

Provisions

249

143

Retirement benefit liability

7,694

7,500

Other

18,981

22,998

Total non-current liabilities

122,758

157,945

Total liabilities

348,938

392,834

Net assets

Shareholders' equity

Share capital

30,685

30,685

Capital surplus

21,833

21,744

Retained earnings

171,996

185,105

Treasury shares

(708)

(6,570)

Total shareholders' equity

223,806

230,964

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

12,969

16,254

Deferred gains or losses on hedges

881

(475)

Foreign currency translation adjustment

40,938

38,774

Remeasurements of defined benefit plans

(1,555)

(1,531)

Total accumulated other comprehensive income

53,233

53,022

Non-controlling interests

8,900

9,980

Total net assets

285,939

293,966

Total liabilities and net assets

634,878

686,801

  1. Quarterly Consolidated Statements of Income and Comprehensive Income

    Quarterly Consolidated Statement of Income

    For the Nine-Month Period

    (Millions of yen)

    For the nine months

    For the nine months

    ended December 31, 2024

    ended December 31, 2025

    Net sales

    663,337

    689,755

    Cost of sales

    558,083

    575,838

    Gross profit

    105,253

    113,916

    Selling, general and administrative expenses

    80,412

    82,498

    Operating profit

    24,840

    31,418

    Non-operating income

    Interest income

    395

    438

    Dividend income

    431

    505

    Foreign exchange gains

    193

    -

    Share of profit of entities accounted for using equity 4,165 2,863

    method

    Subsidy income

    110

    860

    Miscellaneous income

    609

    354

    Total non-operating income

    5,905

    5,022

    Non-operating expenses

    Interest expenses

    2,388

    2,272

    Foreign exchange losses

    -

    101

    Miscellaneous expenses

    450

    274

    Total non-operating expenses

    2,839

    2,648

    Ordinary profit

    27,907

    33,791

    Extraordinary income

    Gain on sale of non-current assets

    119

    409

    Gain on sale of investment securities

    1,874

    1,597

    Gain on bargain purchase

    151

    -

    Gain on liquidation of subsidiaries and associates

    81

    -

    Gain on sale of businesses

    121

    -

    Total extraordinary income

    2,348

    2,007

    Extraordinary losses

    Loss on disposal of non-current assets

    356

    512

    Impairment losses

    -

    1,235

    Loss on sale of investment securities

    -

    3

    Loss on valuation of investment securities

    132

    -

    Loss on disaster

    236

    181

    Total extraordinary losses

    724

    1,932

    Profit before income taxes

    29,530

    33,867

    Income taxes - current

    7,988

    7,732

    Income taxes - deferred

    568

    2,275

    Total income taxes

    8,557

    10,008

    Profit

    20,973

    23,858

    Profit attributable to non-controlling interests

    1,395

    1,512

    Profit attributable to owners of parent

    19,578

    22,346

    Quarterly Consolidated Statement of Comprehensive Income For the Nine-Month Period

    (Millions of yen)

    Comprehensive income attributable to owners of parent

    20,707

    22,135

    Share of other comprehensive income of entities accounted for using equity method

    232

    62

    For the nine months ended December 31, 2024

    For the nine months ended December 31, 2025

    Other comprehensive income

    Deferred gains or losses on hedges

    (365)

    (1,292)

    Remeasurements of defined benefit plans, net of tax

    (88)

    43

    Total other comprehensive income

    1,264

    10

    Comprehensive income attributable to

    Comprehensive income 22,237 23,868

    Foreign currency translation adjustment 1,461 (1,748)

    Valuation difference on available-for-sale securities 24 2,945

    Profit 20,973 23,858

    Comprehensive income attributable to non-controlling

    interests

    1,530 1,733

  2. Notice concerning the consolidated financial statements

(Notes on Going Concern) Not applicable.

(Notes Regarding Significant Changes in the Amount of Shareholders’ Equity)

(Acquisition of treasury stock)

At the Board of Directors meeting held on May 14, 2025, the Company resolved, pursuant to Article 156, Paragraph 1 of the Companies Act as applied by replacing the terms pursuant to Article 165, Paragraph 3 of the same Act and in accordance with the Company’s Articles of Incorporation, to acquire its own shares through a tender offer. As a result, on July 3, 2025, the Company acquired 7,864,875 shares of treasury stock. Mainly due to this acquisition, treasury stock increased by 5,861 million yen, resulting in a balance of 6,570 million yen at the end of the third quarter of the current consolidated fiscal period.

(Segment Information, etc.)

  1. 3rd Quarter of the previous Fiscal Year (April 1, 2024 to December 31, 2024)

    1. Information on net sales and profit (loss) by reportable segment

    (Unit: million yen)

    Information by business segments

    Other (Note1)

    Total

    Adjustment (Note 2)

    Consolidated (Note 3)

    Marine

    Products

    Food

    Products

    Fine

    Chemicals

    General

    Distribution

    Total

    Sales

    270,641

    13,692

    356,112

    808

    10,763

    368

    12,682

    10,464

    650,199

    25,334

    13,137

    991

    663,337

    26,325

    -(26,325)

    663,337

    -

    Total

    284,333

    356,921

    11,132

    23,146

    675,533

    14,128

    689,662

    (26,325)

    663,337

    Segment income (loss)

    5,136

    23,738

    195

    2,326

    31,396

    765

    32,162

    (7,321)

    24,840

    1. Sales to third parties

    2. Inter-segment sales and transfers

    (Note)

    1. The “Other” segment includes the building/repairing of ships, engineering, operation, and other

      businesses not included in the reportable segments.

    2. The (7,321) million yen segment profit adjustment comprises 97 million yen in inter-segment eliminations and (7,418) million yen in corporate expenses not allocated to the segments. Corporate expenses are mainly comprised of selling, general, and administrative expenses not allocated to the segments.

    3. Segment income is adjusted to reflect operating profit as the quarterly income statement records.

  2. Information regarding impairment loss on non-current assets and goodwill by reportable segment

(Significant impairment loss on non-current assets) Not applicable.

(Significant changes in the amount of goodwill)

Not applicable

(Significant gain on negative goodwill) Not applicable.

  1. 3rd Quarter of the current Fiscal Year (April 1, 2025 to December 31, 2025)
    1. Information on net sales and profit (loss) by reportable segment

      (Unit: million yen)

      Information by business segments

      Other (Note 1)

      Total

      Adjustment

      (Note 2)

      Consolidated (Note 3)

      Marine

      Products

      Food

      Products

      Fine

      Chemicals

      General

      Distribution

      Total

      Sales

      279,180

      11,945

      375,638

      2,462

      11,433

      351

      12,739

      10,936

      678,992

      25,696

      10,762

      451

      689,755

      26,148

      -(26,148)

      689,755

      -

      Total

      291,126

      378,101

      11,784

      23,675

      704,688

      11,214

      715,903

      (26,148)

      689,755

      Segment income

      12,463

      24,064

      234

      2,084

      38,846

      366

      39,213

      (7,795)

      31,418

      1. Sales to third parties

      2. Inter-segment sales and transfers

      (Note)

      1. The “Other” segment includes the building/repairing of ships, engineering, operations, and other

        businesses not included in the reportable segments.

      2. The (7,795) million yen segment income adjustment comprises 91 million yen in inter-segment transactions and (7,886) million yen in corporate expenses not allocated to the segments. Corporate expenses are mainly comprised of selling, general, and administrative costs not allocated to the segments.

      3. Segment income is adjusted to reflect operating profit in the quarterly income statement.

    2. Information regarding impairment loss on non-current assets and goodwill by reportable segment (Significant impairment loss on non-current assets)

An impairment loss on non-current assets was recognized in the Marine Products segment and the General Distribution segment. During the nine months ended December 31, 2025, the amounts recognized were 1,159 million yen in the Marine Products segment and 76 million yen in the General Distribution segment.

(Significant changes in the amount of goodwill) Not applicable.

(Significant gain on negative goodwill) Not applicable.

(Note on Statement of Cash Flows)

We have not prepared a quarterly consolidated statement of cash flows for the cumulative consolidated period through the third quarter of the current fiscal year. Depreciation and amortization for the period (including depreciation of noncurrent assets excluding goodwill) and the amount of amortization of goodwill are as follows:

(Unit: million yen)

3rd Quarter of FY2024

(From April 1

to December 31, 2024)

3rd Quarter of FY2025

(From April 1

to December 31, 2025)

Depreciation

18,330

19,297

Amortization of goodwill

475

464

(Significant Subsequent Events)

(Acquisition of a company through the acquisition of shares)

At a meeting of the Board of Directors held on December 16, 2025, the Company resolved to acquire all shares of PESQUERA YADRAN S.A. (“PY”) through its consolidated subsidiary SALMONES ANTARTICA S.A. (“SA”), thereby making PY a wholly owned subsidiary of the Company. In connection with this transaction, the Company entered into a share purchase agreement on December 16, 2025, and, as of January 15, 2026, SA acquired all shares of PY. As a result of SA’s acquisition of all shares of PY and PY’s acquisition of shares of its subsidiaries, the six subsidiaries of PY will also become wholly owned subsidiaries of the Company.

  1. Purpose of Share Acquisition

    In order to realize its long-term vision “GOOD FOODS 2030,” the Nissui Group positions its overseas marine products and food products businesses and fine chemicals business as growth drivers, and aims to build a well-balanced and stable business portfolio between the Food Products Business and the Marine Products Business by 2030.

    Within the Marine Products Business, the aquaculture business is positioned as a key business that can provide sustainable and high-quality protein to people around the world and is expected to achieve an operating profit margin of 10% or more. It is therefore regarded as an initiative that will significantly advance progress toward the long-term vision.

    Amid growing global demand for marine products, salmon is seeing rising demand as an excellent source of protein and as a highly sustainable food ingredient, driven by population growth, diversification of diets, and increasing health consciousness. At the same time, while conditions differ by producing country, environmental regulations and tightening of license frameworks are progressing year by year, limiting room for expansion of farming sites and leading to an expected structural widening of the supply-demand gap going forward.

    Against this backdrop, with PY, which engages in the farming, processing and sales of Atlantic salmon, now joining the Group, the Nissui Group will be able to respond to diverse market needs through a three-species lineup that includes trout and coho salmon from SA, and, having determined that synergies can be expected across the Group as a whole, has decided to make this investment.

  2. The Counterparty to Share Acquisition INVERSIONES YADRAN S.A.

    CHILE MARKET LIMITADA SERVICIOS Y ASESORIAS FINANCIERAS INVERSIONES CRUCOL LIMITADA

  3. Outline of the Company to be Acquired

    Name: PESQUERA YADRAN S.A. and its six subsidiaries Description of business: Salmon aquaculture, processing and sales

  4. Date of Share Acquisition January 15, 2026

  5. Number of Shares to be Acquired, Acquisition Price, and Ownership Ratio After the Acquisition Number of Shares to Be Acquired: 2,524,558,988 shares

Acquisition Price: USD 133,000 thousand (Note)

Note: The acquisition price includes advisory fees and other estimated costs related to this transaction.

Ownership ratio after the acquisition: 100%

(Issuance of Bonds)

The Company resolved at the meeting of its Board of Directors held on January 26, 2026, to issue a Blue Nature Bond (the first series of unsecured corporate bonds). In addition, on February 6, 2026, the Company submitted an amended shelf registration statement for the Issuance to the Director-General of the Kanto Local Finance Bureau.

The proceeds to be raised are planned to be allocated to expenditures related to the Kurose Buri (Japanese amberjack) aquaculture business operated by Kurose Suisan Co., Ltd., a domestic group company, and the FIVE STAR (Salmon) aquaculture business operated by SALMONES ANTARTICA S.A., a group company in Chile. Such expenditures include capital investment, research and development, operations, maintenance and management, renovations, equity investments, and loans.

The specific timing of the Issuance, the total issue amount, the interest rate, and other terms will be determined in the future after comprehensively taking into account demand conditions, interest rate trends, and other factors.